HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Toluene/nail enamel lawsuit

This article was originally published in The Rose Sheet

Executive Summary

San Francisco-based consumer group As You Sow (AYS) files suits against Lee Pharmaceuticals, Dae Doe Corp. and Zauder Brothers alleging that use of the firms' toluene-containing nail polishes exposes individuals to levels of the ingredient that exceed the level determined by the state of California to cause no reproductive harm. AYS asserts that these products therefore must bear the state's Prop 65 warning statement. According to AYS, the three defendants are among a "handful" of firms that have not settled with the consumer group, and AYS plans to file additional suits against other companies that have not settled. The group has settled with 158 companies to date, some of which were not named in its series of lawsuits on the issue but which chose to settle rather than be subject to future lawsuits. AYS filed three complaints April 5 against 43 manufacturers ("The Rose Sheet" April 19, p. 1). Among the firms that have settled are P&G, Cosmair, Maybelline, Chese-Pond's and Avon
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel